Global CRM197 Competitive Landscape Professional Research Report 2024

Research Summary

CRM197 is a non-toxic mutant form of diphtheria toxin, a protein produced by the bacterium Corynebacterium diphtheriae. It is used in the development of certain vaccines as a carrier protein or conjugate. CRM197 lacks the toxic properties of the wild-type diphtheria toxin but retains its ability to bind to the same receptors on cells. This makes it a valuable component in conjugate vaccines, where it is chemically linked to a weak antigen to enhance the body's immune response. By linking CRM197 to a specific antigen from a disease-causing organism, the immune system recognizes both the antigen and the carrier protein, leading to a more robust and long-lasting immune response against the target pathogen. CRM197 has been used successfully in several vaccines, including vaccines against pneumococcal bacteria, Haemophilus influenzae type b, and meningococcal bacteria, helping to protect individuals against these infectious diseases.

According to DIResearch's in-depth investigation and research, the global CRM197 market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of CRM197 include Pfizer, Ligand Pharmaceuticals, CanSino Biologic, Beijing Kexing Biology Product, Scarab Genomics, Xpress Biologics, Fina Biosolutions, Eubiologics, EirGenix etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of CRM197. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global CRM197 market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the CRM197 market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of CRM197 industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of CRM197 Include:

Pfizer

Ligand Pharmaceuticals

CanSino Biologic

Beijing Kexing Biology Product

Scarab Genomics

Xpress Biologics

Fina Biosolutions

Eubiologics

EirGenix

CRM197 Product Segment Include:

Research Grade CRM197

cGMP Grade CRM197

CRM197 Product Application Include:

Pneumococcal Conjugate Vaccine

Meningococcal Polysaccharide Conjugate Vaccine

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global CRM197 Industry PESTEL Analysis

Chapter 3: Global CRM197 Industry Porter's Five Forces Analysis

Chapter 4: Global CRM197 Major Regional Market Size and Forecast Analysis

Chapter 5: Global CRM197 Market Size and Forecast by Type and Application Analysis

Chapter 6: North America CRM197 Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe CRM197 Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China CRM197 Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) CRM197 Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America CRM197 Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa CRM197 Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global CRM197 Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 CRM197 Market Overview

1.1 Product Definition and Statistical Scope

1.2 CRM197 Product by Type

1.2.1 Global CRM197 Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Research Grade CRM197

1.2.3 cGMP Grade CRM197

1.3 CRM197 Product by Application

1.3.1 Global CRM197 Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Pneumococcal Conjugate Vaccine

1.3.3 Meningococcal Polysaccharide Conjugate Vaccine

1.3.4 Others

1.4 Global CRM197 Market Revenue Analysis (2019-2030)

1.5 CRM197 Market Development Status and Trends

1.5.1 CRM197 Industry Development Status Analysis

1.5.2 CRM197 Industry Development Trends Analysis

2 CRM197 Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 CRM197 Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global CRM197 Market Analysis by Regions

4.1 CRM197 Overall Market: 2023 VS 2024 VS 2030

4.2 Global CRM197 Revenue and Forecast Analysis (2019-2030)

4.2.1 Global CRM197 Revenue and Market Share by Region (2019-2024)

4.2.2 Global CRM197 Revenue Forecast by Region (2025-2030)

5 Global CRM197 Market Size by Type and Application

5.1 Global CRM197 Market Size by Type

5.2 Global CRM197 Market Size by Application

6 North America

6.1 North America CRM197 Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America CRM197 Market Size by Type

6.4 North America CRM197 Market Size by Application

6.5 North America CRM197 Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe CRM197 Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe CRM197 Market Size by Type

7.4 Europe CRM197 Market Size by Application

7.5 Europe CRM197 Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China CRM197 Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China CRM197 Market Size by Type

8.4 China CRM197 Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) CRM197 Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) CRM197 Market Size by Type

9.4 APAC (excl. China) CRM197 Market Size by Application

9.5 APAC (excl. China) CRM197 Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America CRM197 Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America CRM197 Market Size by Type

10.4 Latin America CRM197 Market Size by Application

10.5 Latin America CRM197 Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa CRM197 Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa CRM197 Market Size by Type

11.4 Middle East & Africa CRM197 Market Size by Application

11.5 Middle East & Africa CRM197 Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global CRM197 Market Revenue by Key Manufacturers (2020-2024)

12.2 CRM197 Competitive Landscape Analysis and Market Dynamic

12.2.1 CRM197 Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Pfizer

13.1.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Pfizer CRM197 Product Portfolio

13.1.3 Pfizer CRM197 Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Ligand Pharmaceuticals

13.2.1 Ligand Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Ligand Pharmaceuticals CRM197 Product Portfolio

13.2.3 Ligand Pharmaceuticals CRM197 Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 CanSino Biologic

13.3.1 CanSino Biologic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 CanSino Biologic CRM197 Product Portfolio

13.3.3 CanSino Biologic CRM197 Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Beijing Kexing Biology Product

13.4.1 Beijing Kexing Biology Product Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Beijing Kexing Biology Product CRM197 Product Portfolio

13.4.3 Beijing Kexing Biology Product CRM197 Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Scarab Genomics

13.5.1 Scarab Genomics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Scarab Genomics CRM197 Product Portfolio

13.5.3 Scarab Genomics CRM197 Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Xpress Biologics

13.6.1 Xpress Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Xpress Biologics CRM197 Product Portfolio

13.6.3 Xpress Biologics CRM197 Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Fina Biosolutions

13.7.1 Fina Biosolutions Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Fina Biosolutions CRM197 Product Portfolio

13.7.3 Fina Biosolutions CRM197 Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Eubiologics

13.8.1 Eubiologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Eubiologics CRM197 Product Portfolio

13.8.3 Eubiologics CRM197 Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 EirGenix

13.9.1 EirGenix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 EirGenix CRM197 Product Portfolio

13.9.3 EirGenix CRM197 Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 CRM197 Industry Chain Analysis

14.2 CRM197 Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 CRM197 Typical Downstream Customers

14.4 CRM197 Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support